Screener
Ginkgo Bioworks DNA Operating Income
Operating Income at other companies
Other financials
Where this comes from
Reported directly by Ginkgo Bioworks in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The source filing: Ginkgo Bioworks’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:09 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054298
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| General and administrative | 30,775 | 34,981 | 68,605 | 74,704 |
| Restructuring charges | — | 3,566 | — | 8,032 |
| Total operating expenses | 78,704 | 97,297 | 169,552 | 216,499 |
| Loss from operations | (58,548) | (58,163) | (129,922) | (139,135) |
| Other income (expense): | ||||
| Interest income, net | 3,232 | 6,083 | 6,828 | 12,164 |
| Loss on equity method investment | (4,673) | — | (4,673) | — |
| Gain (loss) on investments | 1,987 | (229) | 773 | (3,922) |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Ginkgo Bioworks's operating income?
- Ginkgo Bioworks (DNA) reported operating income of -$58.55M in Q2 2026.
- How has Ginkgo Bioworks's operating income changed year-over-year?
- Ginkgo Bioworks's operating income decreased by 0.7% year-over-year, from -$58.16M to -$58.55M.
- What is the long-term trend for Ginkgo Bioworks's operating income?
- Over 4 years (2021 to 2025), Ginkgo Bioworks's operating income has grown at a -36.4% compound annual growth rate (CAGR), from -$1.83B to -$299.9M.
- What does operating income mean?
- Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.
Ask your AI about Ginkgo Bioworks's operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude